MDGL
NASDAQStockMadrigal Pharmaceuticals, Inc.
$446.27+7.54 (+1.72%)
52-Week Range
$267.56
$602.83
Key Stats
Market Cap
10.1B
P/E Ratio
—
Dividend Yield
—
Beta
-0.96
Volume
144.4K
Avg Volume
347.4K
Performance
1M
-7.40%
3M
-21.73%
6M
+3.09%
YTD
-26.12%
1Y
+25.95%
3Y
+83.72%
5Y
+275.75%
Price Chart
ETF Exposure
MDGL is held by 140 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 2.07% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 1.27% |
| BBP | Virtus Biotech ETF | 1.22% |
| ILDR | First Trust Innovation Leaders ETF | 1.21% |
| GURU | Global X - Guru Index ETF | 1.03% |
| CURE.AX | Global X - S&P Biotech ETF | 1.01% |
| XBI | State Street SPDR S&P Biotech ETF | 1.01% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.96% |
| IBB | iShares Biotechnology ETF | 0.78% |
| FSML | Franklin Small Cap Enhanced ETF | 0.77% |
| FDLS | Inspire Fidelis Multi Factor ETF | 0.77% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.75% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.75% |
| MEDI | Harbor Health Care ETF (MEDI) | 0.73% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.68% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.57% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.55% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.54% |
| IWO | iShares Russell 2000 Growth ETF | 0.53% |
| EQJS.L | Invesco NASDAQ Next Generation 100 UCITS ETF | 0.50% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.49% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.42% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.40% |
| VTWO | Vanguard Russell 2000 ETF | 0.29% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.29% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.28% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.28% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.28% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.28% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.28% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.27% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.27% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.27% |
| IWM | iShares Russell 2000 ETF | 0.27% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.27% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.27% |
| RSSL | Global X - Russell 2000 ETF | 0.27% |
| ANEW | ProShares - MSCI Transformational Changes ETF | 0.24% |
| OPTZ | Optimize Strategy Index ETF | 0.24% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.23% |
| PWS | Pacer WealthShield ETF | 0.23% |
| NXTI | Simplify NEXT Intangible Core Index ETF | 0.22% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.22% |
| STXM | Strive Mid-Cap ETF | 0.22% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.22% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.21% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.20% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.20% |
| UWM | ProShares - Ultra Russell2000 | 0.20% |
| FSMD | FIDELITY SMALL-MID MULTIFACTOR ETF | 0.19% |
Page 1 of 3Next
About MDGL ETF Exposure
Madrigal Pharmaceuticals, Inc. (MDGL) is held by 140 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 10.1B, MDGL is a widely held institutional stock. The stock currently trades at $446.27. Investors can gain exposure to MDGL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MDGL, sorted by portfolio weight.